TP53RK and nephrotic syndrome: An in vivo study recently showed that knockdown of OSGEP and TP53RK resulted in defects in the actin cytoskeleton and a decrease of human podocyte migration rate [9]; these findings are compatible with the pathological manifestation in the development of nephrotic syndrome [9].